Guided Therapeutics, Inc. (GTHP)
Today, GTHP remains (0.00%) +0.000 at $.710 with 44,700 shares in play thus far (ref. google finance Delayed: 11:42AM EDT August 21, 2013).
Guided Therapeutics, Inc. previously reported its operating results for the second quarter and six months ended June 30, 2013.
Revenue and other income for the second quarter of 2013 was approximately $338,000, including $116,000 in sales of LuViva® devices and disposables associated with its European launch, with the remainder of revenue representing contract and grant income. This compares to revenue of approximately $944,000 in the second quarter of 2012, which was comprised almost solely of contract and grant income. Revenue for the first six months of 2013 was $637,000, including $248,000 in sales of LuViva device and disposables. Revenue in the first six months of 2012 was $1.6 million, which was comprised almost solely of contract and grant income. The year over year decline in contract and grant income for both periods was primarily due to bringing the worldwide rights to the Company’s esophageal cancer detection technology back in house.
Top Safest Companies To Own For 2014: Grillit Inc (GRLT)< /h3>
Grillit Inc, formerly Holdings Energy Inc., incorporated on May 21, 2002, is a public corporation that discovers, invests and or acquires development-stage with solutions, clean technologies and eco-friendly products that serve the global alternative energy sector. The Company was formed to develop and engage in operations and management of digital wireless data communications services of 220 megahertz digital wireless data communications. In April 2013, the Company acquired Healthy & Tasty Ventures LLC Effective December 19, 2013, GRILLiT Inc acquired a 10% interest in Natura Foods LLC.
Effective March 30, 2011, the Company had entered into a formal letter of intent with Remington Energy of Houston, Texas for the purchase of two oil and gas properties. On March 29, 2011, the Company disposed of its previous assets that represented the remaining business segment known as CX2 Technologies, Inc.
- [By Peter Graham]
Last Friday, small cap stocks Cambridge Heart, Inc (OTCMKTS: CAMH), Abby Inc (OTCMKTS: ABBY) and Grillit Inc (OTCMKTS: GRLT) surged 176.92%, 71.2% and 24.07%, respectively. Of course, that was last week and today is a new trading week. So what should investors and traders alike be prepared for this week with these three small caps? Here is a closer look to help you decide on an investing or trading strategy:
Top Safest Companies To Own For 2014: XenoPort Inc.(XNPT)
XenoPort, Inc., a biopharmaceutical company, focuses on developing and commercializing internally discovered product candidates that utilize the body?s natural nutrient transport mechanisms to enhance the therapeutic benefits of drugs. The company licenses its lead product candidate Gabapentin Enacarbil, a transported prodrug of gabapentin, to Astellas Pharma Inc. in Japan and five Asian countries, as well as to Glaxo Group Limited in the United States. Astellas Pharma Inc. filed new drug application for the approval of Gabapentin Enacarbil as a treatment for restless legs syndrome in Japan. The company also develops Arbaclofen Placarbil, which completed a Phase II clinical trial for the treatment of spasticity in patients with spinal cord injury. In addition, it develops Arbaclofen Placarbil for the treatment of gastroesophageal reflux disease. Further, the company develops XP21279, which is in Phase II clinical trial for the treatment of Parkinson?s disease; and XP2382 9 , a novel prodrug of methylhydrogenfumarate that is in preclinical stage. It has strategic alliances with Astellas Pharma, Inc. and Glaxo Group Limited. The company was founded in 1999 and is based in Santa Clara, California.
- [By Monica Gerson]
Acceleron Pharma (NASDAQ: XLRN) today announced that it has commenced an underwritten public offering of $100 million of its common stock. To read the full news, click here. XenoPort (NASDAQ: XNPT) announced today that it intends to offer and sell 10,000,000 shares of its common stock, subject to market and other conditions, in an underwritten public offering. To read the full news, click here. Affymetrix (NASDAQ: AFFX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its CytoScan® Dx Assay. To read the full news, click here. Verizon Communications (NYSE: VZ) and Intel (NASDAQ: INTC) today announced an agreement for Verizon to purchase from Intel the assets of Intel Media, a business division dedicated to the development of Cloud TV products and services. To read the full news, click here.
Posted-In: Evercore Partners US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
- [By Sean Williams]
Shareholders of XenoPort (NASDAQ: XNPT ) are also glad for the long weekend after their stock tumbled this week following disappointing late-stage results for Arbaclofen Placarbil, or AP. Aimed at treating spasticity in patients with multiple sclerosis, AP was unsuccessful in delivering a statistically significant benefit compared to the placebo. XenoPort’s management noted that the company plans to cease development of AP and instead focus on the commercial development of recently approved restless leg syndrome drug Horizant, and its remaining clinical pipeline.
Top Safest Companies To Own For 2014: InterContinental Hotels Group PLC (IHG)
InterContinental Hotels Group PLC (IHG), incorporated on May 21, 2004, is a global hotel company, operating seven brands internationally. IHG is the holding company. The principal activities of the Company are in hotels and resorts, with franchising, management, ownership and leasehold interests in over 4,400 establishments, with more than 658,000 guest rooms in over 100 countries and territories worldwide. IHG’s hotels brands include InterContinental Hotels & Resorts, Crowne Plaza Hotels & Resorts, Hotel Indigo, Holiday Inn and Holiday Inn Club Vacations, Holiday Inn Express, Staybridge Suites, Candlewood Suites and Priority Club Rewards. It has four geographical segments: Americas, Europe, Asia, Middle East and Africa (AMEA), and Greater China. As of December 31, 2011, the pipeline totalled 1,144 hotels (180,484 rooms). In March 2012, the Company announced the launch of HUALUXE Hotels and Resorts in China. During the year ended 31 December 2011, it sold four hotels, three in the Americas region and one in the AMEA region. IHG also manages the hotel loyalty program, Priority Club Rewards. As of December 31, 2011, the Company has 3,832 hotels operate under franchise agreements; managed 637 hotels worldwide and owned 11 hotels. During 2011, the Company opened 241hotels (44,265rooms) and removed 98 hotels (33,078 rooms). IHG is focused on the three segments that together generate over 90% of branded hotel revenues: midscale (broadly 3-star hotels), upscale (4-star), and luxury (5-star). InterContinental Hotels & Resorts InterContinental Hotels & Resorts is IHG’s 5-star brand located in cities and resort destinations across more than 60 countries worldwide. Hotels under InterContinental Hotels & Resorts brand are principally managed by the Company. As of December 31, 2011, there were 169 hotels and 57,598 rooms. As of December 31, 2011, it had 51 hotels in development pipeline. Crowne Plaza Hotels & Resorts Crowne Plaza Hotels & Resorts is the IHG’s upscale 4-star segment, specializes in offering modern business and meeting facilities with a service style to provide productive and energising experiences to guests. The majority of hotels under Crowne Plaza Hotels & Resorts brand are principally operated under franchise agreements in the United States and Europe, and are managed by the Company. As of December 31, 2011, there were 387 hotels and 105,104 rooms. As of December 31, 2011, it had 108 hotels in development pipeline. Hotel Indigo Hotel Indigo provides guests with the refreshing design and service experience with a boutique hotel. The Hotels Indigo brand is principally operated under franchise agreements. As of December 31, 2011, there were 39 hotels and 4,564 rooms. As of December 31, 2011, it had 59 hotels in development pipeline Holiday Inn and Holiday Inn Club Vacations The Holiday Inn brand family consists of Holiday Inn, Holiday Inn Express and Holiday Inn Club Vacations. Holiday Inn and Holiday Inn Club Vacations is the midscale hotel brand. Focused on creating an atmosphere where guests can relax, the brand is designed to support both business and leisure travellers. The brand family operates under franchise agreements. As of December 31, 2011, there were 1,240 hotels and 228,256 rooms. As of December 31, 2011, it had 267 hotels in development pipeline. Holiday Inn Express Holiday Inn Express offers convenience and comfort. As of December 31, 2011, there were 2,114 hotels and 196,666 rooms. As of December 31, 2011, it had 470 hotels in development pipeline. Staybridge Suites Staybridge Suites is the Company’s upscale extended stay brand for guests on longer trips, offering studios and suites complete with full kitchens and separate sleeping and work areas in a sociable, family-like atmosphere. Properties under Staybridge Suites brand are operated under a mixture of franchise and management agreements. As of December 31, 2011, there were 179 hotels and 19,567 rooms. As of December 31, 2011, it had 95 hotels in development pipeline. Candlewood Suites Candlewood Suites is the Company’s midscale extended stay brand that gives its guests all the essentials they need for a home-like stay. Properties under Candlewood Suites brand are principally operated under franchise agreements. As of December 31, 2011, there were 285 hotels and 27,500 rooms. As of December 31, 2011, it had 94 hotels in development pipeline. The Company competes with Accor, Choice Hotels International, Inc., Hilton Hotels Corporation, Hyatt, Marriott, Starwood Hotels & Resorts Worldwide, Inc. and Wyndham Worldwide Corporation. Advisors’ Opinion:
- [By Patricio Kehoe]